Doxorubicin-sanguinarine nanoparticles: Formulation and evaluation of breast cancer cell apoptosis and cell cycle

Conclusions: Cellular and molecular studies suggested adjuvant chemosensitizers SA and SN to reverse MDR in breast cancer cells.PMID:38180322 | DOI:10.1080/03639045.2024.2302557

Source: Drug Development and Industrial Pharmacy - January 5, 2024 Category: Drugs & Pharmacology Authors: Mahmoud Zaki El-Readi Majed Abdurhman Abdulkarim Ahmed A H Abdellatif Mohamed E Elzubeir Bassem Refaat Mohammad Althubiti Riyad Adnan Almaimani Mohammed Hasan Mukhtar Issa Saad Al-Moraya Safaa Yehia Eid Source Type: research